Citigroup Portfolio holdings
Citigroup Inc., formed in 1998 through the landmark merger of Citicorp and Travelers Group, with roots tracing back to the 1812 founding of City Bank of New York, is a global financial powerhouse headquartered in New York City, managing trillions in assets. Operating in over 160 countries, Citigroup offers a broad spectrum of services, including consumer banking (via Citibank), investment banking, wealth management, and trading, serving millions of retail customers and major corporations, governments, and institutions worldwide. Under CEO Jane Fraser since 2021—the first woman to lead a major U.S. bank—Citigroup has focused on streamlining operations, exiting consumer banking in 13 markets to bolster its institutional and wealth management focus, while navigating post-2008 regulatory scrutiny and fines. Known for its vast global footprint and resilience through crises, Citigroup remains a key player in international finance, blending retail accessibility with high-stakes capital markets expertise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco Dorsey Wright Momentum ETF
PDP
|
+$591M |
| 2 |
State Street SPDR Dow Jones Industrial Average ETF Trust
DIA
|
+$240M |
| 3 |
Boston Scientific
BSX
|
+$194M |
| 4 |
SCHW
Charles Schwab
SCHW
|
+$193M |
| 5 |
Clarivate
CLVT
|
+$158M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.25B |
| 2 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$809M |
| 3 |
Willis Towers Watson
WTW
|
+$664M |
| 4 |
AstraZeneca
AZN
|
+$658M |
| 5 |
Microsoft
MSFT
|
+$573M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 11.19% |
| 2 | Financials | 6.48% |
| 3 | Consumer Discretionary | 5.4% |
| 4 | Healthcare | 5.05% |
| 5 | Communication Services | 4.03% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
KDMN
2676
DELISTED
Kadmon Holdings, Inc.
KDMN
| $1.63M | ﹤0.01% |
187,016
-470,298
| -72% | -$2.68M |
|
2677
PUT
Lyft
LYFT
$6.02B
| $1.62M | ﹤0.01% |
30,300
-122,000
| -80% | -$6.47M |
|
|
NATI
2678
DELISTED
National Instruments Corp
NATI
| $1.62M | ﹤0.01% |
41,406
-54,240
| -57% | -$2.27M |
|
|
DOOR
2679
DELISTED
MASONITE INTERNATIONAL CORP
DOOR
| $1.62M | ﹤0.01% |
15,280
-8,291
| -35% | -$942K |
|
|
HSKA
2680
DELISTED
Heska Corp
HSKA
| $1.62M | ﹤0.01% |
6,272
-247
| -4% | -$63K |
|
2681
Southwest Gas
SWX
$6.47B
| $1.61M | ﹤0.01% |
24,137
+5,396
| +29% | +$377K |
|
2682
Dr. Reddy's Laboratories
RDY
$9.87B
| $1.61M | ﹤0.01% |
123,840
-147,640
| -54% | -$1.97M |
|
2683
PUT
A.O. Smith
AOS
$8.17B
| $1.61M | ﹤0.01% |
+26,400
| New | +$1.84M |
|
|
VSTO
2684
CALL
DELISTED
Vista Outdoor Inc.
VSTO
| $1.61M | ﹤0.01% |
+40,000
| New | +$1.65M |
|
2685
PMV Pharmaceuticals
PMVP
$59.2M
| $1.61M | ﹤0.01% |
53,885
+406
| +0.8% | +$13K |
|
2686
Simply Good Foods
SMPL
$901M
| $1.6M | ﹤0.01% |
46,411
-1,484
| -3% | -$53.3K |
|
|
GBIO
2687
DELISTED
Generation Bio
GBIO
| $1.6M | ﹤0.01% |
6,383
-9,496
| -60% | -$2.27M |
|
2688
Vanda Pharmaceuticals
VNDA
$307M
| $1.6M | ﹤0.01% |
93,356
-45,560
| -33% | -$798K |
|
|
NLSN
2689
DELISTED
Nielsen Holdings plc
NLSN
| $1.6M | ﹤0.01% |
83,281
-123,617
| -60% | -$2.75M |
|
2690
XPO
XPO
$23.5B
| $1.6M | ﹤0.01% |
33,798
-142,161
| -81% | -$7.12M |
|
2691
TTEC Holdings
TTEC
$121M
| $1.59M | ﹤0.01% |
17,042
-2,633
| -13% | -$269K |
|
2692
OR Royalties Inc
OR
$5.58B
| $1.59M | ﹤0.01% |
141,611
+141,197
| +34,106% | +$1.77M |
|
2693
Patterson-UTI
PTEN
$3.98B
| $1.59M | ﹤0.01% |
176,622
-71,927
| -29% | -$582K |
|
|
FARO
2694
DELISTED
Faro Technologies
FARO
| $1.59M | ﹤0.01% |
24,136
-7,475
| -24% | -$526K |
|
2695
Repay Holdings
RPAY
$331M
| $1.59M | ﹤0.01% |
68,939
+1,883
| +3% | +$44.2K |
|
2696
Brighthouse Financial
BHF
$3.56B
| $1.59M | ﹤0.01% |
35,080
-23,430
| -40% | -$1.06M |
|
2697
Buckle
BKE
$2.25B
| $1.59M | ﹤0.01% |
40,060
-5,768
| -13% | -$246K |
|
|
PARA
2698
PUT
DELISTED
Paramount Global Class B
PARA
| $1.58M | ﹤0.01% |
40,000
| – | – |
|
2699
Pacific Biosciences
PACB
$435M
| $1.58M | ﹤0.01% |
61,711
+10,906
| +21% | +$323K |
|
2700
PUT
Global Payments
GPN
$23B
| $1.58M | ﹤0.01% |
10,000
| – | – |
|
Similar funds
Citigroup's Q3 2021 Portfolio in Review
As of Q3 2021, Citigroup held 6,611 positions worth $169B, up 1.9% from $166B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Citigroup deployed $5.8B of net new capital in Q3 2021, opening 423 new positions and adding to 2,034 existing holdings. Its largest new stake was Hennessy Capital Investment Corp. VI Unit: 9,095,000 shares worth $90.5M.
By sector, the portfolio is most concentrated in Technology at 11% of assets, down from 12% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $2.25B trimmed.
- Citigroup's largest Q3 2021 buy was Hennessy Capital Investment Corp. VI Unit: 9,095,000 shares worth $90.5M.
- Citigroup added most to Invesco Dorsey Wright Momentum ETF in Q3 2021, an estimated $591M increase.
- Citigroup's biggest Q3 2021 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $2.25B.
- Citigroup fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $809M.
- Citigroup's ten largest holdings make up 25% of its $169B portfolio in Q3 2021.
- Citigroup opened 423 new positions and closed 793 in Q3 2021.
- Citigroup's portfolio value rose 1.9% quarter-over-quarter to $169B.
Based on Citigroup's 13F filing for Q3 2021, filed 10 Nov 2021.